Drug Discovery - Rethinking Sustainable Consumables for Drug Discovery Workflows
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

A Practical Guide to Molecular Interaction AnalysisA Practical Guide to Molecular Interaction Analysis

Unlock deeper insight into molecular binding with this practical guide to Isothermal Titration Calorimetry. Learn how to quantify interactions, interpret thermodynamics, validate high throughput assays, and measure enzyme kinetics with confidence. Essential reading for researchers and drug developers advancing molecular level understanding.

Download the Guide
 
 
    Rethinking Sustainable Consumables for Drug Discovery WorkflowsRethinking Sustainable Consumables for Drug Discovery Workflows
 
Automation, sample storage, and reproducibility are essential in drug discovery, but sustainability is becoming equally important. This interview explores how paper-based labware is being engineered for automated liquid handling, cryogenic storage, and high-throughput environments. Learn how sustainable materials are evolving to support modern drug discovery workflows without sacrificing compatibility, durability, or laboratory performance.
Discover the Future of Sustainable Labware
 
 
   How AI and QSAR Modeling Accelerate Ligand-Based Drug DesignHow AI and QSAR Modeling Accelerate Ligand-Based Drug Design
 
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and accelerating therapeutic development.
 
   How Photopharmacology Uses Light-Controlled Drug ActivationHow Photopharmacology Uses Light-Controlled Drug Activation
 
Photopharmacology combines light and drug action, offering reversible control over biological pathways, transforming precision medicine and drug discovery.
 
 How antibody-drug conjugates are redefining targeted cancer therapy
 
How antibody-drug conjugates are redefining targeted cancer therapyAntibody-drug conjugates are rapidly expanding cancer therapies, with 19 approved globally and many more in development, but their success depends on better targets, payloads, linkers, dosing, and patient selection. The Cell review shows that next-generation ADCs could widen treatment options, but safety, resistance, tumor heterogeneity, and clinical translation remain major barriers.
 
 
 The power of organoids in speeding up lifesaving drug development
 
The power of organoids in speeding up lifesaving drug developmentOrganoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult stem cells, etc.) or progenitor cells in an in vitro three-dimensional culture system, which possess structural features and partial functions analogous to their corresponding in vivo organs.
 
 
 Clinical trial challenges long held beliefs about treating brittle bone disease
 
Clinical trial challenges long held beliefs about treating brittle bone diseaseIncreasing bone density in patients with a rare genetic condition that causes bones to break easily does not prevent fractures, a large clinical trial has found.
 
 
 New mechanism to enhance precision in cancer drug development
 
New mechanism to enhance precision in cancer drug developmentResearchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from breaking when cells copy damaged genetic material, a discovery that could affect how certain cancer drugs are developed.
 
 
 UCLA researchers identify potential drug target for treating Fragile X syndrome
 
UCLA researchers identify potential drug target for treating Fragile X syndromeUCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly 1 in 2,000 boys.
 
 
 Compressed Gas Risk Assessment for GMP Utility Systems
 
Compressed Gas Risk Assessment for GMP Utility SystemsGuidance on compressed gas risk assessment within GMP utilities, addressing classification, system criticality, and strategies.
 
 

How would you rate today's newsletter?

 
             
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026